1429 related articles for article (PubMed ID: 10339583)
1. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.
Lorson CL; Hahnen E; Androphy EJ; Wirth B
Proc Natl Acad Sci U S A; 1999 May; 96(11):6307-11. PubMed ID: 10339583
[TBL] [Abstract][Full Text] [Related]
2. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
[TBL] [Abstract][Full Text] [Related]
3. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
[TBL] [Abstract][Full Text] [Related]
4. SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1.
Young PJ; DiDonato CJ; Hu D; Kothary R; Androphy EJ; Lorson CL
Hum Mol Genet; 2002 Mar; 11(5):577-87. PubMed ID: 11875052
[TBL] [Abstract][Full Text] [Related]
5. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.
Hofmann Y; Wirth B
Hum Mol Genet; 2002 Aug; 11(17):2037-49. PubMed ID: 12165565
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.
Monani UR; Lorson CL; Parsons DW; Prior TW; Androphy EJ; Burghes AH; McPherson JD
Hum Mol Genet; 1999 Jul; 8(7):1177-83. PubMed ID: 10369862
[TBL] [Abstract][Full Text] [Related]
7. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
Cartegni L; Krainer AR
Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
[TBL] [Abstract][Full Text] [Related]
8. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA.
Zhang ML; Lorson CL; Androphy EJ; Zhou J
Gene Ther; 2001 Oct; 8(20):1532-8. PubMed ID: 11704813
[TBL] [Abstract][Full Text] [Related]
9. Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing.
DiDonato CJ; Lorson CL; De Repentigny Y; Simard L; Chartrand C; Androphy EJ; Kothary R
Hum Mol Genet; 2001 Nov; 10(23):2727-36. PubMed ID: 11726560
[TBL] [Abstract][Full Text] [Related]
10. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2).
Hofmann Y; Lorson CL; Stamm S; Androphy EJ; Wirth B
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9618-23. PubMed ID: 10931943
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.
Skordis LA; Dunckley MG; Yue B; Eperon IC; Muntoni F
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4114-9. PubMed ID: 12642665
[TBL] [Abstract][Full Text] [Related]
12. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.
Mattis VB; Rai R; Wang J; Chang CW; Coady T; Lorson CL
Hum Genet; 2006 Nov; 120(4):589-601. PubMed ID: 16951947
[TBL] [Abstract][Full Text] [Related]
13. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
Kashima T; Manley JL
Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
[TBL] [Abstract][Full Text] [Related]
15. SMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy?
Heier CR; Gogliotti RG; DiDonato CJ
J Child Neurol; 2007 Aug; 22(8):1013-8. PubMed ID: 17761657
[TBL] [Abstract][Full Text] [Related]
16. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL
Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598
[TBL] [Abstract][Full Text] [Related]
17. Robust quantification of the SMN gene copy number by real-time TaqMan PCR.
Gómez-Curet I; Robinson KG; Funanage VL; Crawford TO; Scavina M; Wang W
Neurogenetics; 2007 Nov; 8(4):271-8. PubMed ID: 17647030
[TBL] [Abstract][Full Text] [Related]
18. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.
Lorson CL; Androphy EJ
Hum Mol Genet; 2000 Jan; 9(2):259-65. PubMed ID: 10607836
[TBL] [Abstract][Full Text] [Related]
19. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.
Riessland M; Brichta L; Hahnen E; Wirth B
Hum Genet; 2006 Aug; 120(1):101-10. PubMed ID: 16724231
[TBL] [Abstract][Full Text] [Related]
20. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.
Andreassi C; Jarecki J; Zhou J; Coovert DD; Monani UR; Chen X; Whitney M; Pollok B; Zhang M; Androphy E; Burghes AH
Hum Mol Genet; 2001 Nov; 10(24):2841-9. PubMed ID: 11734549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]